Volatile Inhibitors of Phosphatidylinositol-3-Kinase (PI3K) Pathway: Anticancer Potential of Aroma Compounds of Plant Essential Oils

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|18|1|87-109

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.18, Iss.1, 2018-03, pp. : 87-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential role of PI3K inhibitors in the treatment of breast cancer

By Carvalho Sílvia   Schmitt Fernando  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1251-1263

Future Medicine

Access to resources Recommend Favorite

Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1048-1056

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 673-687

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

By Peddi Parvin   Hurvitz Sara  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 7-13

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 29-57

Bentham Science Publishers

Access to resources Recommend Favorite